🇺🇸 FDA
Patent

US 9018238

Inhibitor of casein kinase 1δ and casein kinase 1ε

granted A61KA61K31/422A61K31/433

Quick answer

US patent 9018238 (Inhibitor of casein kinase 1δ and casein kinase 1ε) held by Pharmadesign, Inc. expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmadesign, Inc.
Grant date
Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/422, A61K31/433, A61K31/4439, A61P